Advanced Clinical Applications of ICP-MS

40
1 Advanced Clinical Applications of Inductively Coupled Plasma Mass Spectrometry (ICP-MS) “Bring a Little Sunshine into Your Laboratory” Dr Chris Harrington SAS Trace Element Laboratory Guildford

Transcript of Advanced Clinical Applications of ICP-MS

Page 1: Advanced Clinical Applications of ICP-MS

1

Advanced Clinical Applications of

Inductively Coupled Plasma Mass

Spectrometry (ICP-MS)

“Bring a Little Sunshine into Your Laboratory”

Dr Chris HarringtonSAS Trace Element Laboratory

Guildford

Page 2: Advanced Clinical Applications of ICP-MS

2

Overview of Presentation

• Background to ICP-MS

• Comparison to ESI-MS

• Clinical Applications– Nutritional elements

– Orthopaedic applications

– Toxic metals

• Advanced ICP-MS– ICP-MS as a chromatography detector

• Complementary ESI and ICP

• High accuracy IDMS

• New application areas– Biomolecule measurement

– Applications in histopathology

– Applications to flow-cytometry

Page 3: Advanced Clinical Applications of ICP-MS

3

Atmospheric Mass Spectrometry

Electrospray (ESI-MS)

“Soft ionisation” -

molecular and multiply-

charged ions produced.

Inductively coupled plasma

(ICP-MS)

“Hard ionisation” - elemental

ions produced.

Page 4: Advanced Clinical Applications of ICP-MS

4

Comparison of Inorganic and Molecular MS

• Elemental MS

• Strengths

– Provides low LODs (pmol/L).

– Multi-elemental.

– Can be used with most chromatographies

• requires retention time standards for identification.

– High accuracy analysis (ID-MS) is possible.

• Weaknesses

– Requires authentic standards for identification.

– Acquisition and reporting software not as well developed as LC-MS.

• Molecular MS

• Strengths

– Provides low LODs (pmol/L).

– Can be used with most chromatographies

• does not require standards for identification., high mass accuracy.

– High accuracy analysis (ID-MS) is possible for low m/z species.

• Weaknesses

– Ion generation sensitive to matrix components.

– Ultimate LOD not as low as for ICP-MS.

Page 5: Advanced Clinical Applications of ICP-MS

5

Inductively Coupled Plasma

ICP-OES Plasma Cross Section of Plasma

• The plasma temperature is between 7000 and 10 000 K

• Same temperature as the surface of sun.

• Highly charged gas.

Page 6: Advanced Clinical Applications of ICP-MS

6

Sunshine in Action: An Argon Gas Plasma

Page 7: Advanced Clinical Applications of ICP-MS

7

ICP-MS: Detection Limits

Page 8: Advanced Clinical Applications of ICP-MS

8

• Nutritional elements.

• Orthopaedic applications.

• Heavy metal toxicity.

Current Clinical Applications

Page 9: Advanced Clinical Applications of ICP-MS

9

Nutritional Elements

• 26 essential, or suggested, essential elements for humans.

• NICE (2006) Clinical Guideline 32: Nutritional Support in

Adults measurement of Cu, Zn (baseline, 2-4 wks) and Se

(baseline, as required).

• Home PN patients monitored for these plus Mn.

Page 10: Advanced Clinical Applications of ICP-MS

10

Orthopaedic Applications

Interpretation of Co Levels

•< 2 µg/L: close to normal.

•2 - 5 µg/L: equivocal result.

•5 - 10 µg/L: high sensitivity

and specificity for abnormal

wear process.

•10 - 20 µg/L:100%

specificity for abnormal

wear patient at greatly

increased risk of ARMD (adverse reaction to metal debris).

•> 20 µg/L: macroscopic

damage in periprosthetic

tissues, likely osteolysis.

MHRA Guidelines 2010:

Levels of Co and Cr > 7 µg/L

require further investigation

including imaging.

Page 11: Advanced Clinical Applications of ICP-MS

11

Lead use dates back to the Romans, but still

used. Monitoring required for CLAW.

Tetra-ethyllead now banned, but

may have left lasting scarsFcrime!

Blood lead > 0.48 umol/L in children requires

intervention. CDC level half this (>0.24 umol/L).

Mostly lead in old paint

Toxic Elements: As, Cd, Hg, Pb, Tl

Page 12: Advanced Clinical Applications of ICP-MS

12

Advanced Clinical Applications

• ICP-MS as a chromatography detector.– Measurement of drug biomarkers eg DNA-

adducts showing effect of cisplatin

– Metallomics eg identification of Cu-protein interactions in Wilsons Disease.

– High accuracy measurements with traceability for large biomolecules.

Page 13: Advanced Clinical Applications of ICP-MS

ICP-MSExcellent sensitivity

and selectivity

Multi-elemental/isotopic

Quantification

Versatility and easy

coupling

Complementary information

to molecular MS techniques

but easier to interpret.

ESI-MS

MALDI-TOF

FT-ICR

ICP-MS as a Detector for Chromatography

Page 14: Advanced Clinical Applications of ICP-MS

14

Metal Speciation and Metallomics

• Definition:

• ..the qualitative identification and the

quantitative determination, of the individual

chemical forms that comprise the total

concentration of a given trace element in a

sample.(NATO Workshop on Speciation, 1989).

• Significance:• The toxicity of metal(loid)s.

• The biogeochemistry of metal(loid)s.

• The functionality of biometallic species.

Page 15: Advanced Clinical Applications of ICP-MS

15

Clinical Biomarkers of Chemotherapy

• Cisplatin and oxaliplatin are used for the

treatment of many cancers.

• Cisplatin is linked with cellular resistance and

side-effects.

• Both drugs form intrastrand crosslinks

between:

– the N7 positions of two adjacent guanines (GG),

– adjacent adenine-guanines (AG),

– guanines separated by an intervening nucleotide

(GNG).

Page 16: Advanced Clinical Applications of ICP-MS

16

Instrumentation for Speciation Analysis

(b)

(a)

(a) Pt-DNA adduct

measurement system.

(b) API-MS/MS for

characterisation of

metalloproteins and Pt-

standards

Page 17: Advanced Clinical Applications of ICP-MS

17

DNA Sample Preparation

Oasis HLB

• Wash 1 mL MeOH

• Wash 1 mL H2O

• Apply sample in 1 mL

4% MeOH

• Wash column with 1 mL

5% MeOH

• Elute 1mL MeOH

DNAse 1, Nuclease P1, Shrimp

Alkaline Phosphatase

Digestion

8 hours, 37ºC

Solid phase

extraction

-ve ESI-MS/MS

HPLC-ICP-MS

dGpdG + dApdG + dN

CisPt

Dry down and resuspend in

HPLC eluent

dGpdG + dApdG

CisPtCisPt

CisPt

DNA (100µg)Parameter Conditions

Sample DNA extracted from

human blood

Column ACE5 C8

250 x 4.6mm i.d., 5µm

Mobile phase 1 mM TEAA (85%),

methanol (15%) (v/v)

Flow rate 1.0 ml min-1

Injection 20 µl

Interface PEEK tubing (5cm),

Micromist nebuliser.

Detector Q-ICP-MS

-ve ESI-MS/MS

Ion (m/z) 195, 198 ICP

750 - 850 ESI

Page 18: Advanced Clinical Applications of ICP-MS

18

Characterisation of Cisplatin Standard

0

5000

10000

15000

20000

25000

30000

35000

40000

0 2 4 6 8 10

Time (min.)

Response (cps)

m/z 195

m/z 198

HPLC-ICP-MS

F10 ~50pg/ul @ 5ul/min

m/z822 823 824 825 826 827 828 829 830 831 832 833

%

0

100

AM_20110203_014_F10 14 (0.240) Cm (4:30) TOF MS ES+ 6.13e3823.91

822.91

823.41

824.91

824.41

825.91

825.41

826.92

826.41

827.88

827.40

828.86

829.87

830.87 831.89

823

825

824

827

+ve ESI-ToF-MS

[M + H]+ m/z 824

Page 19: Advanced Clinical Applications of ICP-MS

19

Method Validation Data

Parameter

Value

Limit of detection as Pt 110 pmol L-1, 90 ng L-1, 2 pg absolute

Limit of quantitation as Pt 365 pmol L-1, 300 ng L-1, 15 pg absolute

Repeatability 3.4 % (area), 2.3 % (peak height)

Long term precision 7 % (area), 6 % (peak height)

Accuracy 98 %

Sensitivity 6408 cps/ppb (area),

400 cps/ppb (height)

Mean correlation

coefficient (n=5)

0.99991 (area), 0.9843 (height)

Page 20: Advanced Clinical Applications of ICP-MS

20

Results: Cell-lines

Non-small cell lung cancer cell-lines:

A549 cisplatin resistant.

H23 cisplatin sensitive.

Intrastrand adducts repaired by Nucleotide Excision Repair

Cell-Line Adducts

0.00

1.00

2.00

3.00

4.00

5.00

6.00

7h 12h 24h

Time

Adduct

Conc

H23 Sensitive

A549 Resistant

3.13

3.29

2.56

TIC

2.73

Page 21: Advanced Clinical Applications of ICP-MS

21

Results: Human Blood

237ndPatient 8

257ndPatient 7

252ndPatient 6

1245ndPatient 5

113ndPatient 4

214ndPatient 3

343ndPatient 2

146ndPatient 1

After

Treatment

(ng l-1)

Before Treatment

(ng l-1)Identification Human blood sample (10 ml).

Taken 1 hr after drug infusion

Left for 7h prior to DNA

extraction.

GG-CP adduct conc 257 ng L-1.

AG-CP adduct below LOD.

3.13

3.29

2.73

TIC

Page 22: Advanced Clinical Applications of ICP-MS

22

Isotopic Adduct Standard

ESI-MS scan of

enriched

standard.

ESI-MS scan

of natural

standard.

HPLC-ICP-MS analysis of isotopically

enriched cisplatin 198Pt.

This can be used for high accuracy

IDMS measurements.

m/z 195

m/z 198

Page 23: Advanced Clinical Applications of ICP-MS

23

• Autosomal recessive disorder (1 : 30000 in UK).

• Defect in the gene encoding the ATP7B transporter.

• Leads to accumulation of Cu in liver and brain.

• Diagnosed by low serum Cu (<4umol/L), low Cp

(<0.25 g/L), raised Cu urine excretion, Kayser-

Fleischer rings, high liver Cu.

• Clinical presentation hepatic, neurological and

psychiatric.

• Fatal but treatable with Cu chelators.

• Diagnosis hampered by poor specificity Cp assay

lacking differentiation of apo and halo Cp forms.

• Free Cu calculations unreliable.

Cu-Proteins in Wilson’s Disease

Page 24: Advanced Clinical Applications of ICP-MS

24

Cu-Proteins in Wilson’s Disease

Ceruloplasmin (CP)

Albumin (Alb)• Overcomes

problems found

with current CP

assays.

• Apo-CP is not

measured.

Page 25: Advanced Clinical Applications of ICP-MS

25

Metalloprotein Isotopic Enrichment

• Rusticyanin is a small (16 614 Da) copper containing

protein isolated from Acido-thiobacillus ferroxidans.

It was chosen for this study

because:

1) It is well characterised

(XAFS).

2) It has an established

amino acid sequence.

3) It can be generated in

large quantities by a cell

culture and protein

expression system.

Page 26: Advanced Clinical Applications of ICP-MS

26

Standard Production

(a) The expression vector contains the lac promoter

and its neighbouring lacZ gene encoding b-

galactosidase.

(b) If lacZ is replaced by the gene encoding for Rc,

IPTG will stimulate the expression of Rc.

Page 27: Advanced Clinical Applications of ICP-MS

27

HPLC-ICP-MS Analysis: Natural-Cu Rc

0

5000

10000

15000

20000

0 10 20 30

Time (min)

Response (cps)

Enriched-Cu Rc

•An enriched Cu isotope is

inserted into the protein.

•63Cu 0.4 atom % and 65Cu

99.6 atom%.

•This can be used for high

accuracy IDMS

measurements.

0

5000

10000

15000

20000

0 10 20 30

Time (min)

Response (cps)

Natural-Cu Rc

•Shown in red is the

response for 63Cu and in

blue for 65Cu.

•These are in the ratio 2.2:1

reflecting the natural

abundance of Cu.

0

5000

10000

15000

20000

0 10 20 30

Time (min)

Response (cps)

Page 28: Advanced Clinical Applications of ICP-MS

28

Why Not Organic IDMS?

• No difference was observed for the two proteins using

ESIMS. Tris pH 7.0 buffer.

•Would require an instrument with a resolution of 17000.

•By using elemental MS a quadrupole instrument with unit

mass resolution can be used.

• Natural-Cu Rc • Enriched-Cu Rc

Page 29: Advanced Clinical Applications of ICP-MS

29

• High resolution spatial analysis using laser

ablation ICP-MS.

• Metal tagging methods to make molecules

visible to ICP-MS measurement.

• Flow-cytometry for the identification of cell-

types.

New Application Areas

Page 30: Advanced Clinical Applications of ICP-MS

30

• Solid analysis with high spatial resolution.

• Uses:

• Analysis of electrophoresis gels.

• Analysis of metal localization in cells, nails,

hair, brain etc.

• Histopathological analysis of thin-sections

after staining with metal containing ligands.

Laser Ablation-ICP-MS

Page 31: Advanced Clinical Applications of ICP-MS

Quadrupole ICPMS(Agilent 7500ce/cs)

Laser-Ablation(RESOlution M-50

Excimer laser 193 nm (ns-pulses)

+

Laser Ablation-ICP-MS

Schematics of

‘Laurin’ two-volume cell

Page 32: Advanced Clinical Applications of ICP-MS

LA-ICPMS data: TOENAIL

164 µm, 3 Hz, ~4 J/cm2,

193 nm, ≤900 s depth-

profiling.

time [s]

� Clear peaks in As and

Pb resolved by slow

drilling

Hair

44 µm 74 µm

Iceman

finger nail

• Calibration difficult.

• Involves pressing

disks from similar

materials.

• S can be used as

internal standard.

Page 33: Advanced Clinical Applications of ICP-MS

LA-ICP-MS in Histology

• Haematoxylin and eosin are frequently used histological

stains containing Br and Al.

• LA-ICP-MS has resolution down to 10 µm.

• Elemental distribution maps of C, Al, Br & Pt in human

esophageal tumor sections after Cisplatin therapy.

Page 34: Advanced Clinical Applications of ICP-MS

34

• Large molecules can be labelled with trace

elements.

• Antibodies can be tagged with metals

• Aptamers

• Proteins can be derivatized with and then

labelled with metals

Tagging and Labelling

metal -tagged antibody

S N

O

O

R N

n

SS N

O

O

R N

O

O

*

n

N

O

O

R N

O

O

*

n

Page 35: Advanced Clinical Applications of ICP-MS

35

Labelling/Tagging Molecules with Metals

1) Add analyte

2) Add 2nd NP-

tagged antibody

Response cps

m/z

QUANTITATIVE DATA

LA-ICP-MS

HPLC-ICP-MS

m/z

Response cps

STRUCTURAL INFO

MALDI-MS

Recognition

moleculeNanoparticle

Molecular mass

spectrometry

LC-ESI, DESI

STRUCTURAL INFO

Solid support

Nanoparticles include:

Au, Pt, REE (60 atoms).

Analytes include:

peptides; proteins;

DNA-adducts.

Recognition molecules

include: antibodies;

DNA structures.

Page 36: Advanced Clinical Applications of ICP-MS

36

• A variation of conventional flow cytometry

using metal tagged antibodies instead of

fluorochromes

• Detection by ToF-MS of discrete masses of the

metal tags.

• The lack of any significant mass spectral

overlap allows analysis up to 100 parameters

simultaneously on single cells.

• Mass cytometry has applications in

immunology, haematology and oncology.

ICP-TOF-MS Mass Cytometry

Page 37: Advanced Clinical Applications of ICP-MS

Many unique labels available

Cd

5

Se

5

Te

5

24 elements: 67 stable isotopes

La

1

Hf

5

Re

2

Ru

6

Rh

1

Ir

2

Pd

4

Pt

4

Ag

2

Au

1

In

2

Ce

1

Pr

1

Nd

5

Sm

6

Eu

2

Gd

5

Tb

1

Dy

4

Ho

1

Er

4

Tm

1

Yb

5

Lu

1

13 lanthanides: 37 stable isotopes

metal -tagged antibody

S N

O

O

R N

n

SS N

O

O

R N

O

O

*

n

N

O

O

R N

O

O

*

n

37

Flow Cytometry ICP-MS: CyCyCyCyTOF™

Page 38: Advanced Clinical Applications of ICP-MS

Replace fluorophores

and fluorescence =

0

10

20

30

40

50

60

70

80

90

100380

403

426

449

472

495

518

541

564

587

610

633

656

679

702

725

748

771

794

wavelength

inte

nsity

Flow Cytometry ICP-MS: CyCyCyCyTOF™

138 143 148 153 158 163 168 173 178

100

90

80

70

60

50

40

30

20

10

0

with metals and

atomic mass spectrometry

• Abundant tags of similar

intensity

• Discrete signals: minimal

overlap

• No compensation required

• Background cellular

signal: Zero

Page 39: Advanced Clinical Applications of ICP-MS

Concluding Remarks

• ICP-MS has developed from use in the geosciences to

the biosciences.

• Offers blank limited LODs and multi-elemental

capabilities.

• Versatile detector for various separation modes.

• Primary method when used for ID-MS.

• Measurement of S and P offers the potential for high

accuracy analysis of proteins and DNA.

• Tagging molecules with metals opens up many more

possibilities for measurement of biomolecules.

Page 40: Advanced Clinical Applications of ICP-MS

40

Acknowledgements

•Andrew Taylor, Director of SAS Trace Elements

Laboratory, for help, advice and encouragement.

•David Langton, Stockton-Upon-Tees, orthopaedic

studies.

•Andy Duncan, Glasgow Royal Infirmary, Wilsons

Patient samples.

•Wolfgang Muller, Royal Holloway University of

London, LA-ICP-MS of nails.

•Scott Tanner, University of Toronto, CEO CyCyCyCyTOF™.

•MRC and BBSRC for funding.

Thanks for Listening!!